vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.

Orchid Island Capital, Inc. is the larger business by last-quarter revenue ($38.5M vs $23.1M, roughly 1.7× ADC Therapeutics SA). On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 36.4%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

ADCT vs ORC — Head-to-Head

Bigger by revenue
ORC
ORC
1.7× larger
ORC
$38.5M
$23.1M
ADCT
Growing faster (revenue YoY)
ORC
ORC
+336.2% gap
ORC
372.6%
36.4%
ADCT
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
ORC
ORC
Revenue
$23.1M
$38.5M
Net Profit
$103.4M
Gross Margin
Operating Margin
-77.7%
Net Margin
268.7%
Revenue YoY
36.4%
372.6%
Net Profit YoY
1764.9%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
ORC
ORC
Q4 25
$23.1M
$38.5M
Q3 25
$15.8M
$26.9M
Q2 25
$18.1M
$23.2M
Q1 25
$17.4M
$19.7M
Q4 24
$16.9M
Q3 24
$18.0M
$340.0K
Q2 24
$17.0M
$-697.0K
Q1 24
$17.8M
$-2.5M
Net Profit
ADCT
ADCT
ORC
ORC
Q4 25
$103.4M
Q3 25
$-41.0M
$72.1M
Q2 25
$-56.6M
$-33.6M
Q1 25
$-38.6M
$17.1M
Q4 24
Q3 24
$-44.0M
$17.3M
Q2 24
$-36.5M
$-5.0M
Q1 24
$-46.6M
$19.8M
Operating Margin
ADCT
ADCT
ORC
ORC
Q4 25
-77.7%
Q3 25
-196.6%
Q2 25
-244.1%
Q1 25
-163.5%
Q4 24
-191.8%
Q3 24
-197.4%
Q2 24
-170.5%
Q1 24
-188.3%
Net Margin
ADCT
ADCT
ORC
ORC
Q4 25
268.7%
Q3 25
-260.1%
267.8%
Q2 25
-313.2%
-145.0%
Q1 25
-221.8%
86.9%
Q4 24
Q3 24
-244.1%
5094.1%
Q2 24
-214.6%
714.3%
Q1 24
-261.1%
-794.2%
EPS (diluted)
ADCT
ADCT
ORC
ORC
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
Q4 24
$-0.26
Q3 24
$-0.42
Q2 24
$-0.38
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
ORC
ORC
Cash + ST InvestmentsLiquidity on hand
$261.3M
$665.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$1.4B
Total Assets
$323.1M
$11.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
ORC
ORC
Q4 25
$261.3M
$665.9M
Q3 25
$234.7M
$583.9M
Q2 25
$264.6M
$440.8M
Q1 25
$194.7M
$396.4M
Q4 24
$250.9M
Q3 24
$274.3M
$322.1M
Q2 24
$300.1M
$241.0M
Q1 24
$234.3M
$190.4M
Stockholders' Equity
ADCT
ADCT
ORC
ORC
Q4 25
$-185.8M
$1.4B
Q3 25
$-238.2M
$1.1B
Q2 25
$-199.2M
$912.0M
Q1 25
$-238.2M
$855.9M
Q4 24
$-202.6M
Q3 24
$-171.9M
$656.0M
Q2 24
$-131.7M
$555.9M
Q1 24
$-194.4M
$481.6M
Total Assets
ADCT
ADCT
ORC
ORC
Q4 25
$323.1M
$11.7B
Q3 25
$289.8M
$9.1B
Q2 25
$321.6M
$7.6B
Q1 25
$272.5M
$7.3B
Q4 24
$322.0M
Q3 24
$349.1M
$5.9B
Q2 24
$371.8M
$4.9B
Q1 24
$308.0M
$4.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
ORC
ORC
Operating Cash FlowLast quarter
$-31.1M
$120.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
ORC
ORC
Q4 25
$-31.1M
$120.4M
Q3 25
$-29.6M
$28.0M
Q2 25
$-24.1M
$18.4M
Q1 25
$-56.3M
$25.8M
Q4 24
$-21.9M
Q3 24
$-25.0M
$-14.8M
Q2 24
$-32.8M
$19.3M
Q1 24
$-44.1M
$45.0M
Free Cash Flow
ADCT
ADCT
ORC
ORC
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
Q3 24
$-25.3M
Q2 24
$-32.9M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
ORC
ORC
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
Q3 24
-140.2%
Q2 24
-193.0%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
ORC
ORC
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
Q3 24
1.2%
Q2 24
0.2%
Q1 24
3.0%
Cash Conversion
ADCT
ADCT
ORC
ORC
Q4 25
1.16×
Q3 25
0.39×
Q2 25
Q1 25
1.51×
Q4 24
Q3 24
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons